Rituximab Monotherapy Is Effective in Treating Orbital Necrobiotic Xanthogranuloma.


The authors report a case of a patient with bilateral orbital necrobiotic xanthogranuloma and no associated systemic paraproteinemia. Orbital biopsy showed strong expression of CD20-positive cells. The patient was treated with systemic rituximab monotherapy, with excellent clinical response and marked regression of the orbital lesions on imaging. At the… (More)
DOI: 10.1097/IOP.0000000000000988